lactic acid has been researched along with thioguanine anhydrous in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Beije, B; Jenssen, D | 1 |
| Tsuchiya, T | 1 |
| Chanda, N; Chatterjee, M; Hens, A; Jaiswal, N; Mahata, N | 1 |
4 other study(ies) available for lactic acid and thioguanine anhydrous
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Investigation of styrene in the liver perfusion/cell culture system. No indication of styrene-7,8-oxide as the principal mutagenic metabolite produced by the intact rat liver.
Topics: Animals; Blood Proteins; Cells, Cultured; Cricetinae; Cricetulus; Epoxy Compounds; Ethers, Cyclic; In Vitro Techniques; Lactates; Lactic Acid; Liver; Liver Function Tests; Male; Microsomes, Liver; Mutagens; Rats; Rats, Inbred Strains; Styrene; Styrenes; Subcellular Fractions; Thioguanine | 1982 |
A useful marker for evaluating tissue-engineered products: gap-junctional communication for assessment of the tumor-promoting action and disruption of cell differentiation in tissue-engineered products.
Topics: Animals; Antineoplastic Agents; Biomedical Engineering; Carcinogens; Cell Differentiation; Cell Division; Cell Line; Connexins; Cricetinae; Dose-Response Relationship, Drug; Drug Resistance; Embryo, Mammalian; Fibroblasts; Gap Junctions; Lactic Acid; Neurons; Phenotype; Polyurethanes; Povidone; Rats; Rats, Wistar; Silicones; Tetradecanoylphorbol Acetate; Thioguanine; Vanadates | 2000 |
Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
Topics: Delayed-Action Preparations; Drug Carriers; HeLa Cells; Humans; Lactic Acid; Nanoparticles; Neoplasms; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Thioguanine | 2020 |